Kausch-Whipple Procedure – Surgery and Prognosis

What is the Kausch-Whipple Procedure?

The Kausch-Whipple procedure, medically known as pancreaticoduodenectomy, is one of the most complex operations in abdominal surgery. It was first performed in 1909 by the German surgeon Walter Kausch and later refined in 1935 by the American surgeon Allen Oldfather Whipple, whose name the procedure most commonly bears. The operation is primarily used to treat tumors located in the head of the pancreas, the duodenum, and surrounding upper abdominal structures.

Indications – When is the Procedure Performed?

The Kausch-Whipple procedure is indicated in the following situations:

• Pancreatic head carcinoma: Malignant tumor in the head of the pancreas – the most common indication
• Ampullary carcinoma: Tumor at the junction of the bile duct and pancreatic duct where they enter the small intestine
• Distal cholangiocarcinoma: Cancer of the lower bile duct
• Duodenal carcinoma: Cancer of the duodenum (first section of the small intestine)
• Chronic pancreatitis: Severe inflammation of the pancreas with complications
• Benign tumors: Non-cancerous growths in the pancreatic head region (e.g., IPMN, cystadenomas)

Surgical Procedure – What is Removed?

During the classic Kausch-Whipple procedure, the following structures are removed:

• The head of the pancreas
• The duodenum (first part of the small intestine)
• The distal stomach (lower portion, approximately 40 %)
• The gallbladder and distal bile duct
• Surrounding lymph nodes

After removal of these structures, the continuity of the digestive tract is restored through three surgical connections (anastomoses): between the remaining pancreas and the small intestine (pancreaticojejunostomy), between the bile duct and the small intestine (hepaticojejunostomy), and between the remaining stomach and the small intestine (gastrojejunostomy).

Pylorus-Preserving Variant

In the modern pylorus-preserving pancreaticoduodenectomy (PPPD), the pylorus (the outlet of the stomach) is left intact. In suitable patients, this variant is oncologically equivalent to the classic approach and better preserves gastric function, which can contribute to improved long-term quality of life.

Preoperative Preparation

Comprehensive diagnostic workup is performed before the procedure to assess tumor resectability and the patient's general health. This typically includes:

• Imaging: CT scan, MRI, and possibly endoscopic ultrasound
• Laboratory tests (blood count, liver and kidney function, tumor markers such as CA 19-9)
• Assessment of comorbidities (cardiac and pulmonary function)
• Nutritional optimization and, if necessary, biliary drainage in cases of jaundice

Risks and Complications

The Kausch-Whipple procedure is technically demanding and carries significant risks. The most common complications include:

• Delayed gastric emptying (most frequent complication): Slowed stomach function in the postoperative period
• Pancreatic fistula: Leakage at the connection between the remaining pancreas and the intestine
• Wound infections and intra-abdominal abscesses
• Bleeding
• Bile leaks
• Diabetes mellitus: Loss of pancreatic tissue may impair insulin production
• Exocrine pancreatic insufficiency: Reduced production of digestive enzymes

In specialized high-volume centers, the mortality rate of this procedure is now below 3–5 %, a significant improvement compared to earlier decades.

Postoperative Care and Rehabilitation

Following surgery, patients typically remain in hospital for 10–14 days. The overall recovery period lasts several weeks. Key aspects of postoperative care include:

• Taking pancreatic enzyme supplements (e.g., pancreatin) with meals to compensate for exocrine insufficiency
• Blood sugar monitoring and insulin therapy if new-onset diabetes develops
• Adapted diet: small, frequent meals and a low-fat diet in the initial recovery phase
• Regular oncological follow-up appointments for cancer patients
• Adjuvant chemotherapy after resection of pancreatic carcinoma, as indicated

Prognosis

The prognosis depends strongly on the underlying condition. For patients with completely resected pancreatic head carcinoma, the 5-year survival rate is approximately 15–25 %, which represents a significantly better outlook compared to inoperable disease. For benign conditions or early-stage tumors (e.g., ampullary carcinoma), the prognosis can be considerably more favorable.

References

1. Strobel O, Neoptolemos J, Jaeger D, Buechler MW. Optimizing the outcomes of pancreatic cancer surgery. Nature Reviews Clinical Oncology, 2019; 16(1): 11–26.
2. Leitlinienprogramm Onkologie. S3 Guideline Exocrine Pancreatic Cancer. AWMF Registration No.: 032-010OL, Version 3.1, 2021. Available at: https://www.leitlinienprogramm-onkologie.de
3. Whipple AO, Parsons WB, Mullins CR. Treatment of carcinoma of the ampulla of Vater. Annals of Surgery, 1935; 102(4): 763–779.